fb-pixel tracker
News

Novel Findings for Molecular Profiling of Head and Neck Squamous Cell Carcinoma (HNSCC) Presented at the 2012 Multidisciplinary Head & Neck Cancer Symposium

First Comprehensive Analysis of Biomarkers Associated with this Aggressive Form of Cancer Demonstrates Clinical Utility of Molecular Profiling in Identifying Treatment Options When Therapeutic Ambiguities Exist. IRVING, TX, February 2, 2012 – Caris Life Sciences™, Inc., a leading biosciences company focused on enabling precise and personalized healthcare through the highest quality molecular profiling and blood-based … Continued

Caris Life Sciences and Miraca Holdings Complete Sale of Anatomic Pathology Business

Tokyo, Japan & Irving, Texas – November 22, 2011 – Miraca Holdings Inc. (“Miraca”), Japan’s largest clinical diagnostics and laboratory testing service provider, and Caris Life Sciences, Inc. (“CLS”), a privately-held company headquartered in Texas specializing in the development and commercialization of the highest quality anatomic pathology, molecular profiling, and blood-based diagnostic technologies, today announced … Continued

Caris Life Sciences Presents Study at AACR-NCI-EORTC International Conference

Data Highlights How the Information Provided by Molecular Profiling Can Be Useful in Guiding Therapy Selection for Advanced Prostate Cancer IRVING, Texas – November 17, 2011 – Caris Life Sciences™, Inc., a leading biosciences company focused on enabling precise and personalized healthcare through the highest quality anatomic pathology, molecular profiling, and blood-based diagnostic services, this … Continued

Caris Life Sciences Reports Key Findings at the 59th Annual Scientific Meeting of the American Society of Cytopathology

Data Highlights Clinical Utility of Molecular Profiling in Absence of Traditional Tissue Samples IRVING, Texas – November 8, 2011 – Caris Life Sciences, Inc.™, a leading biosciences company focused on enabling precise and personalized healthcare through the highest quality anatomic pathology, molecular profiling and blood-based diagnostics, prognostic and theranostic services, announced today that Erika Fong, … Continued

Kathleen Danenberg Joins Caris Life Sciencesā€™ Executive Team as Senior Vice President, Professional Affairs

Newly Added Position Will Develop and Expand Molecular Profiling Clinical Trial Strategy IRVING, Texas – October 19, 2011 – Caris Life Sciences, Inc.™, a leading biosciences company focused on enabling precise and personalized healthcare through the highest quality anatomic pathology, molecular profiling, and blood-based diagnostic, prognostic and theranostic services, announced today that Kathleen Danenberg has … Continued

Caris Life Sciences Highlights Gene Expression Profiling Findings at 12th Annual International Congress of Human Genetics

Data Presented Shows Clinical Utility of Molecular Profiling Helping Physicians Select More Effective Therapeutic Treatments for Cancer Patients   IRVING, TX, October 14-15, 2011 — Caris Life Sciences™, Inc., a leading biosciences company focused on enabling precise and personalized healthcare through the highest quality molecular profiling, and blood-based diagnostic services, presented this week at the … Continued

Caris Life Sciences Presents Key Biomarker Findings at 2011 ASCO Breast Cancer Symposium

Data Highlights Potential Clinical Utility of Molecular Profiling in Uncovering Therapeutic Options to Treat Breast Cancer IRVING, TX, September 13, 2011 — Caris Life Sciences™, Inc., a leading biosciences company focused on enabling precise and personalized healthcare through the highest quality anatomic pathology, molecular profiling, and blood-based diagnostic services, this week at the ASCO Breast … Continued

Caris Life Sciences Announces Key Findings in Cancer Biomarker Expression

HER2 Gene Overexpression Found in Array of Cancers Beyond Breast Cancer IRVING, TX, June 06, 2011 — Caris Life Sciences™, Inc., a leading biosciences company focused on enabling precise and personalized healthcare through the highest quality anatomic pathology, molecular profiling, and blood-based diagnostic services, announced today that its recent research highlights the clinical utility of … Continued

Caris Life Sciences Presents Circulating Microvesicle Research Findings at American Urological Association Annual Meeting

Data Shows Diagnostic Promise for Blood-Based Prostate Cancer Detection Test IRVING, TX, May 18, 2011 — Caris Life Sciences, Inc., a leading bioscience company focused on enabling precise and personalized healthcare through the highest quality anatomic pathology, molecular profiling and blood-based diagnostic services, this weekend presented a poster highlighting the potential of a circulating microvesicle … Continued

1 17 18 19 20

About Our News

Search to find the latest new about Caris Molecular IntelligenceĀ®, sign up for news alerts, and be sure to follow us on social media.